As FDA decision looms, Alnylam triples Kendall footprint, plans to double staff
August 07, 2018 at 05:50 AM EDT
Alnylam is moving forward with plans to double its office and manufacturing space, as well as its staff, by 2020. The FDA will decide on the company's first drug this week.
